Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 29 Jun 2007 |
| Grant of Warrants to Board Members, Management and Employees in Genmab A/S | 27 Jun 2007 |
| Genmab Reaches First Milestone in Ofatumumab Collaboration | 26 Jun 2007 |
| Genmab Announces Development Plans for Ofatumumab | 18 Jun 2007 |
| GlaxoSmithKline and Genmab Present Positive Phase II Results with Ofatumumab in Patients with Rheumatoid Arthritis (RA) | 15 Jun 2007 |